JP2021509198A5 - - Google Patents

Download PDF

Info

Publication number
JP2021509198A5
JP2021509198A5 JP2020535175A JP2020535175A JP2021509198A5 JP 2021509198 A5 JP2021509198 A5 JP 2021509198A5 JP 2020535175 A JP2020535175 A JP 2020535175A JP 2020535175 A JP2020535175 A JP 2020535175A JP 2021509198 A5 JP2021509198 A5 JP 2021509198A5
Authority
JP
Japan
Prior art keywords
model
neuron
physiological
patient
ranges
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020535175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021509198A (ja
JP7106646B2 (ja
Filing date
Publication date
Priority claimed from US15/856,582 external-priority patent/US11227692B2/en
Application filed filed Critical
Publication of JP2021509198A publication Critical patent/JP2021509198A/ja
Publication of JP2021509198A5 publication Critical patent/JP2021509198A5/ja
Application granted granted Critical
Publication of JP7106646B2 publication Critical patent/JP7106646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020535175A 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム Active JP7106646B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/856,582 2017-12-28
US15/856,582 US11227692B2 (en) 2017-12-28 2017-12-28 Neuron model simulation
PCT/IB2018/059697 WO2019130135A1 (en) 2017-12-28 2018-12-06 Neuron model generation for personalised drug treatment

Publications (3)

Publication Number Publication Date
JP2021509198A JP2021509198A (ja) 2021-03-18
JP2021509198A5 true JP2021509198A5 (https=) 2021-04-30
JP7106646B2 JP7106646B2 (ja) 2022-07-26

Family

ID=67058418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020535175A Active JP7106646B2 (ja) 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム

Country Status (5)

Country Link
US (1) US11227692B2 (https=)
JP (1) JP7106646B2 (https=)
CN (1) CN111465852B (https=)
DE (1) DE112018006656T5 (https=)
WO (1) WO2019130135A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021063937A1 (en) * 2019-09-30 2021-04-08 F. Hoffmann-La Roche Ag Means and methods for assessing huntington´s disease (hd)
CN112582069B (zh) * 2020-12-25 2023-01-17 南开大学 基于反应扩散模型的神经元树突棘发育模式建立方法
CN113161016A (zh) * 2020-12-31 2021-07-23 上海明品医学数据科技有限公司 一种智能医学服务系统、方法及存储介质
CN114358622B (zh) * 2022-01-07 2024-11-08 中创新航技术研究院(江苏)有限公司 工厂仿真方法及装置

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5121231A (en) * 1990-04-06 1992-06-09 University Of Southern California Incoherent/coherent multiplexed holographic recording for photonic interconnections and holographic optical elements
US5849995A (en) 1993-09-27 1998-12-15 The University Of British Columbia Mouse model for Huntington's Disease and related DNA sequences
AUPP398898A0 (en) 1998-06-09 1998-07-02 University Of Queensland, The Diagnostic method and apparatus
DE19832053A1 (de) * 1998-07-16 2000-01-27 Siemens Ag Verfahren zur Ermittlung des im Rahmen des Parkinson-Syndroms bzw. der Parkinson-Krankheit relevanten klinischen Zustands eines Patienten, sowie System hierfür
US6933147B2 (en) * 2000-08-17 2005-08-23 Icagen, Inc. Human cyclic nucleotide-gated channel polypeptide
US7461006B2 (en) 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
US20040241720A1 (en) * 2003-02-26 2004-12-02 Salkoff Lawrence B. Sodium activated potassium ion channel for therapeutic drug screening
US20080038730A1 (en) * 2004-05-10 2008-02-14 Heinz Von Der Kammer Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
JP5307397B2 (ja) * 2004-09-18 2013-10-02 ユニバーシティ オブ メリーランド，ボルチモア ＮＣＣａ−ＡＴＰチャネルを標的とする治療剤およびその使用方法
CA2590377A1 (en) * 2004-12-16 2006-06-22 Novascreen Biosciences A method for identification and functional characterization of agents which modulate ion channel activity
KR20070111475A (ko) * 2005-01-04 2007-11-21 노파르티스 아게 만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
CA2628108C (en) 2005-11-10 2020-01-07 Certara Usa, Inc. Method and apparatus for computer modeling the human brain for predicting drug effects
US7945392B2 (en) 2005-11-14 2011-05-17 Mclean Hospital Corporation Methods and systems for drug screening and computational modeling based on biologically realistic neurons
EP3703058A1 (en) 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
US20090306534A1 (en) * 2006-04-03 2009-12-10 President And Fellows Of Harvard College Systems and methods for predicting effectiveness in the treatment of psychiatric disorders, including depression
CN103424541B (zh) * 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
JP5670755B2 (ja) * 2008-03-12 2015-02-18 ザ ロックフェラー ユニバーシティ 翻訳プロファイリング及び分子表現型解析のための方法及び組成物
CA2725138A1 (en) * 2008-05-21 2009-11-26 Kinemed, Inc. Compositions and methods of treatment using modulators of motoneuron diseases
WO2009152485A2 (en) * 2008-06-13 2009-12-17 Ipierian, Inc. Methods of cell-based technologies
CN101658522B (zh) * 2008-08-26 2013-01-02 香港理工大学深圳研究院 他克林短链二聚体类化合物在制备治疗神经退行性疾病药物中的应用
JP2012521767A (ja) * 2009-03-26 2012-09-20 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 薬剤代謝に影響を及ぼすｃｙｐ３ａ４遺伝子における多型およびその使用
EP2603900B1 (en) * 2010-08-13 2024-04-24 Intellimedicine, Inc. System and methods for the production of personalized drug products
BR112014003811A2 (pt) * 2011-08-26 2017-03-14 Hoffmann La Roche método para predizer benefício clínico no tratamento de transtornos de neurodesenvolvimento, neurológicos ou neuropsiquiátricos
US20130262155A1 (en) 2012-04-03 2013-10-03 Thomas J. HinKamp System and method for collection and distibution of medical information
US9466024B2 (en) * 2013-03-15 2016-10-11 Northrop Grumman Systems Corporation Learning health systems and methods
JP2014239871A (ja) * 2013-05-07 2014-12-25 安東　秀夫 生体活動検出方法、生体活動測定装置、生体活動検出信号の転送方法および生体活動情報を利用したサービスの提供方法
US20140358512A1 (en) * 2013-06-03 2014-12-04 International Business Machines Corporation Automated construction of ion-channel models in a multi-comparment models
CN111710434B (zh) * 2013-08-19 2021-10-26 塞弗欧米公司 用于确定对蛋白质的功能的影响的方法和系统
WO2015085432A1 (en) * 2013-12-13 2015-06-18 The Governors Of The University Of Alberta Systems and methods of selecting compounds with reduced risk of cardiotoxicity
US20150301030A1 (en) * 2014-04-22 2015-10-22 Q-State Biosciences, Inc. Models for parkinson's disease studies
EP3006055B1 (en) * 2014-10-10 2020-02-19 Albert-Ludwigs-Universität Freiburg Improved biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases
KR101617683B1 (ko) * 2015-01-09 2016-05-03 연세대학교 산학협력단 부정맥 치료제 효과 평가 시스템 및 방법
US11179192B2 (en) * 2015-07-29 2021-11-23 Atricure, Inc. Ablation devices and methods of use
EP3410926A4 (en) * 2016-02-01 2019-08-28 The Board of Trustees of the Leland Stanford Junior University METHOD AND SYSTEMS FOR ANALYZING FUNCTIONAL IMAGING DATA
CN105998316B (zh) * 2016-05-23 2019-12-03 齐齐哈尔医学院 一种治疗老年性痴呆的中药组合物及其具体制备方法和相关应用
CN120636518A (zh) * 2017-05-12 2025-09-12 密歇根大学董事会 个体和队列药理学表型预测平台
EP3723844B1 (en) * 2017-12-12 2023-08-09 Duke University Systems and methods for minimizing response variability of spinal cord stimulation

Similar Documents

Publication Publication Date Title
Vincent et al. With an eye on uncertainty: Modelling pupillary responses to environmental volatility
JP2021509198A5 (https=)
De Jong et al. Variation in hospital length of stay: do physicians adapt their length of stay decisions to what is usual in the hospital where they work?
Bair et al. Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study
Lubetzky et al. On the effects of signal processing on sample entropy for postural control
WO2020220545A1 (zh) 基于长短期记忆模型的疾病预测方法、装置和计算机设备
JP2013524355A5 (https=)
JP2017523841A5 (https=)
Akachi et al. Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002–2008
Niles et al. Advancing personalized medicine: application of a novel statistical method to identify treatment moderators in the coordinated anxiety learning and management study
JP7634464B2 (ja) 介入効果分析システム、及び介入効果分析方法
Stewart et al. Implications of process error in selectivity for approaches to weighting compositional data in fisheries stock assessments
Karlsson et al. Psychometric characteristics of the Hospital Anxiety and Depression Scale in stroke survivors of working age before and after inpatient rehabilitation
JPWO2021245733A5 (ja) 脳画像解析装置、制御方法、及びプログラム
TWI774964B (zh) 患病機率預測方法與電子裝置
KR20240146701A (ko) Xr 인터랙션 사용자의 가상 태스크 수행 효율성 분석 장치 및 방법
KR20230037432A (ko) 사용자의 치매 정도 결정 방법 및 장치
JPWO2022119754A5 (https=)
KR102127449B1 (ko) 생존율 예측 모델 생성 방법, 장치 및 컴퓨터 프로그램
Ricard et al. Validation of models for analysis of ranks in horse breeding evaluation
CN118675689A (zh) 一种基于下肢康复器械的康复方案生成方法和装置
Finch Recursive partitioning in the presence of multilevel data
JPWO2020217359A5 (ja) フィッティング支援装置、フィッティング支援方法、及びプログラム
Molas et al. Hurdle models for multilevel zero‐inflated data via h‐likelihood
WO2023072513A1 (en) Contextualizing the analysis of medical images